<DOC>
	<DOCNO>NCT00723892</DOCNO>
	<brief_summary>Several psychiatric adverse event ( eg , depression , fatigue , psychosis , behavior trouble , anxiety , irritability , deteriorate concentration , insomnia ) likely occur treatment course PegIntron plus Rebetol may prompt patient discontinue treatment early . The goal study ass whether psychotherapy support program may contribute good adherence rate .</brief_summary>
	<brief_title>Adherence Patients Receiving PegIntron/Rebetol Hepatitis C Conjunction With Psychotherapy Support Program ( Study P04252 )</brief_title>
	<detailed_description>Enrollment participant occur sequential order treatment initiation .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Adult patient hepatitis C According product ' labeling</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>